|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of central portion of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.111 |
Malignant neoplasm of central portion of right female breast
Diagnosis Valid for Female Patient Only
|
C50111 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 60.61%
|
24.35%
|
7.01%
|
3.14%
|
1.68%
|
0.97%
|
0.71%
|
0.41%
|
0.33%
|
0.21%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.111*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
17,110
|
17,191
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
13,053
|
13,055
|
|
80053
|
COMPREHEN METABOLIC PANEL |
12,821
|
12,821
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
10,785
|
10,809
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
8,105
|
8,154
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
4,739
|
5,196
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
2,993
|
2,993
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
2,394
|
2,440
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
2,390
|
5,338
|
|
77066
|
DX MAMMO INCL CAD BI |
2,173
|
2,173
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,143
|
3,778
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,134
|
11,159
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
2,062
|
16,693
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,814
|
61,614
|
|
77336
|
RADIATION PHYSICS CONSULT |
1,797
|
1,797
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,772
|
7,136
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
1,761
|
1,840
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,722
|
1,723
|
|
77065
|
DX MAMMO INCL CAD UNI |
1,684
|
1,684
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
1,585
|
71,667
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.111 related to the following DRG Codes:
582-583
597-599
|
